Monitoring hepatic artery spasm for chemotherapeutic infusion by using Tc-99m labeled macroaggregated albumin.
During angiographic placement of an intra-arterial hepatic catheter, a spasm was encountered in the proper hepatic artery. Subsequent angiography, however, revealed normal arteries. Tc-99m MAA intra-arterial infusion was then performed which showed a hepatic artery spasm. Twenty-four hours after the initial hepatic arterial spasm, a repeat injection of Tc-99m MAA revealed that the spasm was no longer present and, therefore, that intra-arterial chemotherapy could be administered.
D000328:Adult; D002404:Catheterization / Q000009:adverse effects; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D006499:Hepatic Artery / Q000187:drug effects; D006801:Humans; D007261:Infusions, Intra-Arterial / Q000009:adverse effects*; D008113:Liver Neoplasms / Q000188:drug therapy; D011877:Radionuclide Imaging; D012709:Serum Albumin; D013035:Spasm / Q000000981:diagnostic imaging* / Q000209:etiology; D013667:Technetium; D013668:Technetium Tc 99m Aggregated Albumin
D012709:Serum Albumin; D013668:Technetium Tc 99m Aggregated Albumin; D013667:Technetium; D004317:Doxorubicin